Vertaile menetelmiä

	Berliinin kysely uniapnean seulontaan	Uniikki unen tilan indikaattori
Tieteenala	Unilääketiede	Unilääketiede
Menetelmäperhe	Process / pipeline	Process / pipeline
Syntyvuosi	1999	2014
Kehittäjä	Netzer, N. C., Stoohs, R. A., Netzer, C. M., et al.	Espie, C. A., Kyle, S. D., Hames, P., et al.
Tyyppi	Self-report	Self-report
Alkuperäislähde	Netzer, N. C., Stoohs, R. A., Netzer, C. M., Clark, K., & Strohl, K. P. (1999). Using the Berlin Questionnaire to identify patients at risk for the sleep apnea syndrome. Annals of Internal Medicine, 131(7), 485-491.	Espie, C. A., Kyle, S. D., Hames, P., Cbermack, R. A., & Morin, C. M. (2014). A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via a mobile application. Sleep, 37(9), 1553-1563.
Rinnakkaisnimet	Berlin Sleep Apnea Questionnaire	Sleep Condition Indicator, SCI Insomnia Scale
Liittyvät	3	3
Tiivistelmä	The Berlin Questionnaire is a 10-item screening instrument designed to identify patients at risk for obstructive sleep apnea in primary care and community settings. Developed by Netzer and colleagues in 1999, it uses a three-category scoring approach (snoring symptoms, daytime somnolence, and hypertension/obesity) to stratify OSA risk. The tool is particularly useful in general population screening and has been extensively validated across international cohorts and clinical populations.	The Sleep Condition Indicator (SCI) is an 8-item self-report scale designed to assess the severity of insomnia symptoms in adults in a manner closely aligned with DSM-5 diagnostic criteria for insomnia disorder. Developed by Espie and colleagues in 2014, it measures the core features of insomnia: difficulty initiating sleep, difficulty maintaining sleep, early morning awakening, daytime impairment, and associated distress. The SCI is increasingly used in clinical practice and research to screen for insomnia, monitor treatment response, and evaluate cognitive-behavioral therapy efficacy.